Boston Scientific Corp (BSX) financials · P/E 18, rev $20.07B
Lician Pro · $19.99/mo or $149/yrCompare AAPL vs MSFT
Boston Scientific Corp (BSX) P/E 18, rev $20.07B.
| Line | FY2025 | FY2024 |
|---|---|---|
| Revenue | $20.07B | $16.75B |
| Cost of Revenue | $6.22B | $5.26B |
| Gross Profit | $13.85B | $11.49B |
| Operating Income | $3.61B | $2.60B |
| Net Income | $2.89B | $1.85B |
| EPS (Diluted) | $1.94 | $1.25 |
| Line | FY2025 | FY2024 |
|---|---|---|
| Total Assets | $43.67B | $39.40B |
| Current Assets | $8.79B | $6.92B |
| Cash & Equivalents | $1.97B | $414.0M |
| Inventory | $2.94B | $2.81B |
| PP&E | $4.04B | $3.29B |
| Total Liabilities | $19.44B | $17.63B |
| Current Liabilities | $5.44B | $6.40B |
| Short-term Debt | $299.0M | $1.78B |
| Total Debt | $11.14B | $10.75B |
| Shareholders' Equity | $24.23B | $21.77B |
| Retained Earnings | $5.57B | $2.67B |
| Line | FY2025 | FY2024 |
|---|---|---|
| Operating Cash Flow | $4.53B | $3.44B |
| CapEx | $876.0M | $790.0M |
| Investing Cash Flow | -$2.64B | -$5.69B |
| Financing Cash Flow | -$395.0M | $1.81B |
| Dividends Paid | N/A | $0 |
| Net Change in Cash | $1.54B | -$450.0M |
| Free Cash Flow | $3.66B | $2.65B |
FAQ
What is BSX P/E and revenue?
Boston Scientific Corp (BSX) P/E 18, rev $20.07B.
What is BSX revenue?
Boston Scientific Corp last cached revenue is $20.07B (FY2025).
Is BSX profitable?
Boston Scientific Corp last cached net income is $2.89B (FY2025).
What are BSX total assets?
Boston Scientific Corp last cached total assets are $43.67B (FY2025).
What is BSX free cash flow?
Boston Scientific Corp last cached free cash flow is $3.66B (FY2025).
Not investment advice. Cached statements, not a live tape.